| Oral administration of angiotensin-(1–7) ameliorates type 2 diabetes in rats SHS Santos, JF Giani, V Burghi, JG Miquet, F Qadri, JF Braga, M Todiras, ... Journal of Molecular Medicine 92, 255-265, 2014 | 97 | 2014 |
| Angiotensin-(1–7) attenuates diabetic nephropathy in Zucker diabetic fatty rats JF Giani, V Burghi, LC Veiras, A Tomat, MC Muñoz, G Cao, D Turyn, ... American Journal of Physiology-Renal Physiology 302 (12), F1606-F1615, 2012 | 94 | 2012 |
| The Mas receptor mediates modulation of insulin signaling by angiotensin-(1–7) MC Muñoz, JF Giani, V Burghi, MA Mayer, A Carranza, CA Taira, ... Regulatory peptides 177 (1-3), 1-11, 2012 | 76 | 2012 |
| Modulation of the action of insulin by angiotensin-(1–7) FP Dominici, V Burghi, MC Munoz, JF Giani Clinical science 126 (9), 613-630, 2014 | 64 | 2014 |
| Upregulation of the angiotensin-converting enzyme 2/angiotensin-(1–7)/Mas receptor axis in the heart and the kidney of growth hormone receptor knock-out mice JF Giani, JG Miquet, MC Muñoz, V Burghi, JE Toblli, MM Masternak, ... Growth Hormone & IGF Research 22 (6), 224-233, 2012 | 27 | 2012 |
| Validation of commercial Mas receptor antibodies for utilization in Western Blotting, immunofluorescence and immunohistochemistry studies V Burghi, NC Fernández, YB Gándola, VG Piazza, DT Quiroga, ... PloS one 12 (8), e0183278, 2017 | 24 | 2017 |
| Chronic blockade of the AT2 receptor with PD123319 impairs insulin signaling in C57BL/6 mice MC Muñoz, V Burghi, JG Miquet, IA Cervino, DT Quiroga, L Mazziotta, ... Peptides 88, 37-45, 2017 | 21 | 2017 |
| A reversible SRC-relayed COX2 inflammatory program drives resistance to BRAF and EGFR inhibition in BRAFV600E colorectal tumors A Ruiz-Saenz, CE Atreya, C Wang, B Pan, CA Dreyer, D Brunen, ... Nature Cancer 4 (2), 240-256, 2023 | 19 | 2023 |
| Involvement of histamine H1 and H2 receptor inverse agonists in receptor's crossregulation AD Nebreda, CD Zappia, AR González, A Sahores, M Sosa, V Burghi, ... European Journal of Pharmacology 847, 42-52, 2019 | 17 | 2019 |
| Participation of Gαi-Adenylate Cyclase and ERK1/2 in Mas Receptor Signaling Pathways V Burghi, EB Echeverría, MH Sosa, DT Quiroga, MC Muñoz, C Davio, ... Frontiers in Pharmacology 10, 146, 2019 | 16 | 2019 |
| Biased agonism at histamine H1 receptor: Desensitization, internalization and MAPK activation triggered by antihistamines V Burghi, EB Echeverría, CD Zappia, AD Nebreda, S Ripoll, N Gómez, ... European Journal of Pharmacology 896, 173913, 2021 | 10 | 2021 |
| The regulator of G protein signaling homologous domain of G protein-coupled receptor kinase 2 mediates short-term desensitization of β3-adrenergic receptor E Echeverría, M Cabrera, V Burghi, M Sosa, S Ripoll, A Yaneff, F Monczor, ... Frontiers in Pharmacology 11, 113, 2020 | 9 | 2020 |
| Identification of inhibitors of the RGS homology domain of GRK2 by docking-based virtual screening E Echeverría, AJV Rueda, M Cabrera, E Juritz, V Burghi, L Fabián, ... Life sciences 239, 116872, 2019 | 7 | 2019 |
| Gαs is dispensable for β-arrestin coupling but dictates GRK selectivity and is predominant for gene expression regulation by β2-adrenergic receptor V Burghi, JS Paradis, A Officer, SA Garcia, X Wu, ESF Matthees, ... Journal of Biological Chemistry, 105293, 2023 | 2 | 2023 |
| Insulin signaling in the heart is impaired by growth hormone: a direct and early event MC Muñoz, VG Piazza, V Burghi, JF Giani, CS Martinez, NS Cicconi, ... Journal of Molecular Endocrinology 69 (2), 357-376, 2022 | | 2022 |
| DOWNREGULATION OF THE ANGIOTENSIN-CONVERTING ENZYME 2/ANGIOTENSIN-(1-7)/MAS RECEPTOR AXIS IN HEART AND KIDNEY OF TRANSGENIC MICE OVEREXPRESSING GROWTH HORMONE MC Muñoz, V Burghi, JG Miquet, JF Giani, RD Banegas, JE Toblli, ... The Journal of endocrinology 221 (2), 215, 2014 | | 2014 |
